XML 44 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION
9 Months Ended
Dec. 31, 2023
Supplemental Information Condensed Financial Information  
SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION

NOTE 21 – SUPPLEMENTAL INFORMATION CONDENSED FINANCIAL INFORMATION FOR THE NINE MONTHS ENDED DECEMBER 31, 2023, AND 2022.

 

The Singing Machine Company, Inc. and Subsidiaries

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the nine months ended December 31, 2023 and 2022

SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 

   December 31, 2023   December 31, 2022 
   Nine Months Ended 
   December 31, 2023   December 31, 2022 
       (unaudited) 
         
Net Sales  $29,198,000   $35,916,000 
           
Cost of Goods Sold   23,008,000    27,481,000 
           
Gross Profit   6,190,000    8,435,000 
           
Operating Expenses   12,333,000    9,986,000 
           
(Loss) Income from Operations   (6,143,000)   (1,551,000)
           
Other (Expenses) Income   (255,000)   (574,000)
           
(Loss) Income Before Income Tax Benefit   (6,398,000)   (2,125,000)
           
Income Tax Benefit (Loss)   -    472,000 
           
Net (Loss) Income  $(6,398,000)  $(1,653,000)
           
Loss per Common Share          
Basic and Diluted   (1.32)   (0.61)
           
Weighted Average Common and Common          
Equivalent Shares:          
Basic and Diluted   4,864,540    2,699,210 

 

 

THE SINGING MACHINE COMPANY, INC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2023, and March 31, 2023 and 2022

 

The Singing Machine Company, Inc. and Subsidiaries

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the nine months ended December 31, 2023 and 2022 (unaudited)

 SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

   December 31, 2023   December 31, 2022 
   For the Nine Months Ended 
   December 31, 2023   December 31, 2022 
       (unaudited) 
         
Cash flows from operating activities          
Net loss  $(6,398,000)  $(1,653,000)
Adjustments to reconcile net loss to net cash used in operating activities:   1,305,000    (73,000)
Changes in operating assets and liabilities:   5,504,000    (538,000)
Net cash provided by (used in) operating activities   411,000    (2,264,000)
Cash flows from investing activities          
Net cash used in investing activities   (14,000)   (149,000)
Cash flows from financing activities          
Net cash provided by financing activities   3,411,000    2,917,000 
Net change in cash   3,808,000    504,000 
    -    - 
Cash at beginning of year   2,895,000    2,291,000 
Cash at end of period  $6,703,000   $2,795,000 

 

 

THE SINGING MACHINE COMPANY, INC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2023, and March 31, 2023 and 2022

 

The Singing Machine Company, Inc. and Subsidiaries

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

For the nine months ended December 31, 2023 and 2022 (unaudited)

SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY  

   Shares   Amount   Capital   Receivable   Deficit   Total 
   Common Stock   Additional Paid in   Subscriptions   Accumulated     
   Shares   Amount   Capital   Receivable   Deficit   Total 
Balance at March 31, 2023   3,167,488   $32,000   $29,822,000   $(6,000)  $(19,517,000)  $10,331,000 
Net loss   -    -    -    -    (6,398,000)   (6,398,000)
Issuance of common stock, net of stock offering costs   3,250,573    32,000    3,497,000    -    -    3,529,000 
Stock based compensation   -    -    110,000    -    -    110,000 
Other   -    -    -    6,000    -    6,000 
                               
 Balance at December 31, 2023   6,418,061   $64,000    33,429,000   $-   $(25,915,000)  $7,578,000 

 

   Common Stock   Additional Paid in   Subscriptions   Accumulated     
   Shares   Amount   Capital   Receivable   Deficit   Total 
Balance at March 31, 2022   1,221,209   $12,000   $24,903,000   $     -   $(14,879,000)  $10,036,000 
Net loss   -    -    -    -    (1,653,000)   (1,653,000)
Issuance of common stock and warrants, net of stock offering costs   1,909,519    19,000    4,489,000    -    -    4,508,000 
Stock based compensation   15,803    -    307,000    -    -    307,000 
Other   1,688    -    -    -    -    - 
                               
Balance at December 31, 2022 (unaudited)   3,148,219   $31,000    29,699,000   $-   $(16,532,000)  $13,198,000